Click to access each resource:
Please find the session links next to their corresponding agenda item.
Thursday, October 27
11:00 AM
FDLI Welcome and Announcements
Khara L. Minter, Assistant Director, Training Programs, FDLI
Enter this session: https://fdli.zoom.us/j/83615847281
11:05 AM–12:20 PM
Biosimilar Biological Products
William Holtz, Principal, Leavitt Partners, LLC
Enter this session: https://fdli.zoom.us/j/83615847281
12:20–12:30 PM
Break
12:30–1:15 PM
Post-Approval Pharmacovigilance
Nathan A. Beaver, Partner, Foley & Lardner LLP
Enter this session: https://fdli.zoom.us/j/89058401351
1:15–1:25 PM
Break
1:25–2:25 PM
Regulation of Biological Manufacturing
Christopher Fanelli, Partner, Sidley Austin LLP
Enter this session: https://fdli.zoom.us/j/87636489773
2:25–2:35 PM
Break
2:35–3:35 PM
Regulation of Biological Product Marketing
Nathan A. Beaton, Associate, Latham & Watkins LLP
Kathryn Culver, Associate, Latham & Watkins LLP
Enter this session: https://fdli.zoom.us/j/81045973182
3:35–3:45 PM
Break
3:45–5:00 PM
Violations, Enforcement, and International Issues
Rebecca Williams, Associate, Ropes & Gray LLP
Enter this session: https://fdli.zoom.us/j/84160694796
5:00 PM
Adjournment
CLE Information
Ohio
This event is pending approval in Ohio. To obtain credit, please email [email protected] at the end of the conference and include your state bar number along with how many credits you wish to obtain. FDLI will certify your attendance for you. An evaluation and completed quiz is required to obtain credit.
Virginia
This event is pending approval in Virginia. Please email [email protected] to request a Virginia form. You will need to certify your attendance online at www.vsb.org. Retain the Certificate of Attendance for two years.
Other States
These CLE approvals may also be honored by other states; please check with your bar association for guidance. At the end of the conference, please email [email protected] to receive a certificate of attendance.